Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Biosyent Inc V.RX

Alternate Symbol(s):  BIOYF

Healthcare
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

TSXV:RX - Post Discussion

Biosyent Inc > Combogesic
View:
Post by overnout on Mar 16, 2021 8:17am

Combogesic

New treatment option offers a clinically proven 3.3:1 acetaminophen to ibuprofen ratio

MISSISSAUGA, ON, March 16, 2021 /CNW/ -  BioSyent Inc. ("BioSyent", "the Company"), (TSXV: RX) is pleased to announce Combogesic® is now available in many pharmacies across Canada. Combogesic® is indicated for the short-term management of mild to moderate acute pain and the reduction of fever in adults over 18 years. Combogesic® is the first Health Canada approved combination analgesic that provides the double action of two well-known and effective medicines, acetaminophen and ibuprofen, in one - patented formulation - tablet.

Comment by lscfa on Mar 16, 2021 10:18am
Can be ordered on-line. $15.49 for 30 pack. Now people just need to find out about it.  https://www.pharmexdirect.com/product/combogesic/  
Comment by lscfa on Mar 22, 2021 5:33pm
" Combogesic sales in 4Q-20 were only the result of wholesaler stocking, however feedback from customers has been positive." - Bloom Burton
Biosyent Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities